查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726197

細胞和基因療法第三方物流市場規模、佔有率、趨勢分析報告：按類型、產品、溫度範圍、治療領域、最終用途、地區、細分市場、預測，2025-2030 年

Cell And Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report By Type, By Product, By Temperature Range, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

細胞和基因治療第三方物流市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球細胞和基因治療第三方物流市場預計到2030年將達到200.4億美元，2025年至2030年期間的複合年成長率為11.05%。

該市場的成長主要受到細胞和基因療法日益成長的需求的推動，這需要精確的處理、嚴格的溫度控制以及製造商、醫院和治療中心之間的無縫協調。 CGT 是針對特定患者的，這意味著必須在有限的時間內收集、運輸、修改和重新註入單一患者的細胞。任何後勤上的失敗都可能意味著失去昂貴的、可能挽救生命的治療方法。 CGT的個人化特性推動了對先進低溫運輸物流的需求，超低溫儲存和運輸成為標準要求。

此外，CGT 的臨床試驗和商業批准不斷增加，要求物流供應商擴大其產能，確保增加的治療劑量能夠送達患者，且不會影響品質。這種轉變迫使生物製藥公司尋求專業的第三方物流合作夥伴，以應對 CGT 供應鏈的複雜性，最佳化物流效率，同時確保遵守嚴格的監管要求。此外，不斷增加的監管支持也促進了市場成長。美國FDA、EMA等全球監管機構對CGT的運輸和儲存實施了嚴格的指導，以維持其功效和安全性。為了遵守法規，物流供應商必須實施良好分銷規範 (GDP) 和良好生產規範 (GMP)，這兩項規範涵蓋了從包裝到即時追蹤的供應鏈管理的所有方面。不遵守規定可能會導致貨物被拒收，從而造成經濟損失並延誤患者護理。

此外，市場參與企業不斷增加的舉措，如夥伴關係和聯盟、服務擴展、產品發布和增加研發線產品，都促進了市場成長。例如，2025 年 3 月，DHL 收購了生命科學溫控物流專家 CryoPDP。此次收購旨在加強該公司處理先進醫療治療的基礎設施。 CryoPDP 在超低溫儲存和即時監控解決方案方面的專業知識與 DHL 為生物製藥公司提供端到端解決方案的策略一致。

細胞和基因治療第三方物流市場報告重點

  • 根據類型，臨床領域佔據市場主導地位，因為市場參與者增加了研發活動，細胞治療和基因治療的產品平臺也在增加。
  • 從產品來看，由於監管部門核准的增加和商業化的擴大，細胞療法預計將在 2024 年佔據市場主導地位。 CAR-T 細胞療法在癌症治療中的成功在這一成長中發揮了關鍵作用，其中諾華、吉利德科學和百時美施貴寶等公司處於領先地位。
  • 根據溫度範圍，由於對不需要超低溫或低溫的基因療法、生技藥品和再生醫學產品的需求不斷增加，常溫儲存在 2024 年佔據了最大的市場佔有率。
  • 從治療領域來看，由於迅速採用先進療法治療各種癌症，尤其是血液腫瘤和固體癌，腫瘤學在 2024 年佔據了市場主導地位。
  • 根據最終用途，由於生技藥品和特殊藥物高度依賴溫控儲存和運輸，預計生物製藥公司將在 2024 年佔據最大的市場佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 科技
  • 定價模式分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章細胞和基因治療第三方物流市場：按類型估計和趨勢分析

  • 細分儀表板
  • 細胞和基因治療第三方物流市場：類型變化分析
  • 細胞及基因治療第三方物流規模及趨勢分析（按類型）（2018-2030）
  • 臨床
  • 商業的

第5章細胞和基因治療第三方物流市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 細胞和基因治療第三方物流市場：產品差異分析
  • 細胞及基因治療第三方物流規模及趨勢分析（依產品）（2018-2030）
  • 細胞療法
  • 基因治療

第6章細胞和基因治療第三方物流市場：按溫度範圍的估計和趨勢分析

  • 細分儀表板
  • 細胞和基因治療第三方物流市場：溫度範圍變化分析
  • 2018-2030年細胞與基因治療第三方物流規模及趨勢分析（依溫度範圍）
  • 常溫保存
  • 冷藏保管
  • 超低溫儲存
  • 低溫儲存

第7章細胞和基因治療第三方物流市場：按治療領域估計和趨勢分析

  • 細分儀表板
  • 細胞與基因治療第三方物流市場：治療領域差異分析
  • 細胞與基因治療第三方物流規模及趨勢分析（依治療領域）（2018-2030）
  • 腫瘤學
  • 神經病學
  • 心血管疾病
  • 眼科
  • 感染疾病
  • 其他

8. 細胞和基因治療第三方物流市場：按最終用途的估計和趨勢分析

  • 細分儀表板
  • 細胞和基因治療第三方物流市場：最終用途差異分析
  • 細胞和基因治療第三方物流規模和趨勢分析（按最終用途）（2018-2030）
  • 生物製藥公司
  • CDMO/CMO
  • 其他

第9章區域業務分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 2018年至2030年北美細胞和基因治療第三方物流市場估計和預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲細胞與基因治療第三方物流市場預測
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太細胞與基因治療第三方物流市場預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018年至2030年拉丁美洲細胞和基因治療第三方物流市場估計和預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲細胞和基因治療第三方物流市場估計和預測（2018 - 2030）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Cencora Corporation
    • Cardinal Health
    • McKesson Corporation
    • EVERSANA
    • Knipper Health
    • Arvato SE
    • DHL
    • FedEx
    • Kuehne+Nagel
    • United Parcel Service of America, Inc.
Product Code: GVR-4-68040-550-5

Cell & Gene Therapy Third-Party Logistics Market Growth & Trends:

The global cell and gene therapy third-party logistics market is expected to reach USD 20.04 billion by 2030, expanding at a CAGR of 11.05% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to rising demand for cell and gene therapies, which require precise handling, strict temperature controls, and seamless coordination between manufacturers, hospitals, and treatment centers. CGTs are patient-specific, which signifies that a single patient's cells must be collected, transported, modified, and reinfused within tight timelines. Any failure in logistics can result in the loss of an expensive, potentially life-saving therapy. The personalized nature of CGTs has increased the need for advanced cold chain logistics, with cryogenic storage and ultra-low temperature transportation becoming standard requirements.

In addition, the growing pipeline of CGT clinical trials and commercial approvals encourages logistics providers to scale their capabilities, ensuring that the increasing volume of therapies reaches patients without compromising quality. This shift is compelling biopharmaceutical companies to seek specialized 3PL partners that can handle the complexities of CGT supply chains, ensuring compliance with strict regulatory requirements while optimizing distribution efficiency. Moreover, the growing regulatory support is also one of the factors contributing to market growth. The U.S. FDA, EMA, and other global regulatory bodies impose stringent guidelines on the transportation and storage of CGTs to maintain their potency and safety. Regulatory compliance requires logistics providers to implement Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) standards, which govern every aspect of supply chain management, from packaging to real-time tracking. Failure to comply can result in rejected shipments, financial losses, and treatment delays for patients.

Furthermore, growing initiatives by the market players, such as partnerships and collaborations, service expansion, product launches, and increasing pipeline products, contribute to market growth. For instance, in March 2025, DHL acquired CryoPDP, a specialist in temperature-controlled logistics for life sciences. The acquisition aims to strengthen the infrastructure for handling advanced therapies. CryoPDP's expertise in ultra-cold storage and real-time monitoring solutions aligns with DHL's strategy, providing end-to-end solutions for biopharma companies.

Cell And Gene Therapy Third-Party Logistics Market Report Highlights:

  • Based on type, the clinical segment dominated the market due to the increasing number of research and development activities by the market players coupled with the growing number of cell and gene therapies product pipelines.
  • Based on the product, cell therapies dominated the market in 2024 due to increasing regulatory approvals and expanding commercialization efforts. The success of CAR-T cell therapies for cancer treatment played a crucial role in this growth, with companies like Novartis, Gilead Sciences, and Bristol Myers Squibb driving widespread adoption.
  • Based on temperature range, ambient storage held the largest market share in 2024due to the increasing demand for gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
  • Based on the therapeutic area, the oncology segment dominated the market in 2024due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic and solid tumors.
  • Based on end use, biopharmaceutical companies held the largest market share in 2024due to their high reliance on temperature-controlled storage and transportation for biologics and specialty drugs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Technology Landscape
  • 3.5. Pricing Model Analysis
  • 3.6. Industry Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Cell & Gene Therapy Third-Party Logistics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Cell & Gene Therapy Third-Party Logistics Market; Type Movement Analysis
  • 4.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Clinical
    • 4.4.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Commercial
    • 4.5.1. Commercial market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell & Gene Therapy Third-Party Logistics Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Cell & Gene Therapy Third-Party Logistics Market; Product Movement Analysis
  • 5.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Cell Therapies
    • 5.4.1. Cell therapies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Gene Therapies
    • 5.5.1. Gene therapies market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Cell & Gene Therapy Third-Party Logistics Market; Temperature Range Movement Analysis
  • 6.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
  • 6.4. Ambient Storage
    • 6.4.1. Ambient storage market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Refrigerated Storage
    • 6.5.1. Refrigerated storage market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Ultra-Low Temperature Storage
    • 6.6.1. Ultra-Low temperature storage market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Cryogenic Storage
    • 6.7.1. Cryogenic storage market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Cell & Gene Therapy Third-Party Logistics Market; Therapeutic Area Movement Analysis
  • 7.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Neurology
    • 7.5.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Cardiovascular Diseases
    • 7.6.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Ophthalmology
    • 7.7.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. Infectious Diseases
    • 7.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Cell & Gene Therapy Third-Party Logistics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Cell & Gene Therapy Third-Party Logistics Market; End Use Movement Analysis
  • 8.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Biopharmaceutical Companies
    • 8.4.1. Biopharmaceutical Companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. CDMOs/CMOs
    • 8.5.1. CDMOs/CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. U.S. cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Canada cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Mexico cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Germany cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. UK cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. France cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Italy cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Spain cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Denmark cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Sweden cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Competitive scenario
      • 9.4.9.3. Regulatory framework
      • 9.4.9.4. Norway cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Japan cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. China cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. India cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. South Korea cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Australia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Competitive scenario
      • 9.5.7.3. Regulatory framework
      • 9.5.7.4. Thailand cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Brazil cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Regulatory framework
      • 9.6.3.4. Argentina cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. South Africa cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Saudi Arabia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. UAE cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Competitive scenario
      • 9.7.5.3. Regulatory framework
      • 9.7.5.4. Kuwait cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Share/Assessment Analysis, 2024
  • 10.3. Company Profiles
    • 10.3.1. Cencora Corporation
      • 10.3.1.1. Company overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Service benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Cardinal Health
      • 10.3.2.1. Company overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Service benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. McKesson Corporation
      • 10.3.3.1. Company overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Service benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. EVERSANA
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Service benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Knipper Health
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Service benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Arvato SE
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Service benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. DHL
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Service benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. FedEx
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Service benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Kuehne+Nagel
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Service benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. United Parcel Service of America, Inc.
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Service benchmarking
      • 10.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 6 Global Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 7 Global Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Cell & Gene Therapy Third-Party Logistics Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 12 North America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 13 North America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 14 North America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 18 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 19 U.S. Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Canada Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 23 Canada Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 Canada Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 28 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Mexico Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Europe Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Europe Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 34 Europe Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 35 Europe Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 UK Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 UK Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 UK Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 39 UK Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 40 UK Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Germany Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Germany Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Germany Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 44 Germany Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 45 Germany Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 France Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 France Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 France Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 49 France Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 50 France Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Italy Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 53 Italy Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 54 Italy Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Italy Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 Spain Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Spain Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 59 Spain Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Spain Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 64 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 Denmark Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 69 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 Sweden Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Norway Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Norway Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 74 Norway Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 75 Norway Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Japan Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Japan Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Japan Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 85 Japan Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 Japan Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 China Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 China Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 China Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 90 China Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 China Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 India Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 India Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 India Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 95 India Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 96 India Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Australia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 98 Australia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 99 Australia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 100 Australia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 Australia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 102 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 103 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 104 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 105 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 South Korea Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 108 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 110 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 111 Thailand Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 116 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 117 Latin America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 119 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 120 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 121 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Brazil Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 124 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 125 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 126 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 127 Argentina Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 MEA Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 MEA Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 130 MEA Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 131 MEA Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 MEA Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 133 MEA Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 135 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 136 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 137 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 138 South Africa Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 145 UAE Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 146 UAE Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 147 UAE Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 148 UAE Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Cell & Gene Therapy Third-Party Logistics Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Cell & Gene Therapy Third-Party Logistics Market: Type Key Takeaways
  • Fig. 14 Global Cell & Gene Therapy Third-Party Logistics Market: Type Movement Analysis
  • Fig. 15 Global Cell & Gene Therapy Third-Party Logistics Market, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell & Gene Therapy Third-Party Logistics Market, for Commercial, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell & Gene Therapy Third-Party Logistics Market: Product Key Takeaways
  • Fig. 18 Global Cell & Gene Therapy Third-Party Logistics Market: Product Movement Analysis
  • Fig. 19 Global Cell & Gene Therapy Third-Party Logistics Market, for Cell Therapies, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell & Gene Therapy Third-Party Logistics Market, for Gene Therapies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Key Takeaways
  • Fig. 22 Global Cell & Gene Therapy Third-Party Logistics Market, Temperature Range Movement Analysis
  • Fig. 23 Global Cell & Gene Therapy Third-Party Logistics Market, for Ambient Storage, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell & Gene Therapy Third-Party Logistics Market, for Refrigerated Storage, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell & Gene Therapy Third-Party Logistics Market, for Ultra-Low Temperature Storage, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell & Gene Therapy Third-Party Logistics Market, for Cryogenic Storage, 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Key Takeaways
  • Fig. 28 Global Cell & Gene Therapy Third-Party Logistics Market, Therapeutic Area Movement Analysis
  • Fig. 29 Global Cell & Gene Therapy Third-Party Logistics Market, Oncology, 2018 - 2030 (USD Million)
  • Fig. 30 Global Cell & Gene Therapy Third-Party Logistics Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 31 Global Cell & Gene Therapy Third-Party Logistics Market, for cardiovascular diseases, 2018 - 2030 (USD Million)
  • Fig. 32 Global Cell & Gene Therapy Third-Party Logistics Market, for Ophthalmology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Cell & Gene Therapy Third-Party Logistics Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 34 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 35 Global Cell & Gene Therapy Third-Party Logistics Market: End Use Key Takeaways
  • Fig. 36 Global Cell & Gene Therapy Third-Party Logistics Market, End Use Movement Analysis
  • Fig. 37 Global Cell & Gene Therapy Third-Party Logistics Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 38 Global Cell & Gene Therapy Third-Party Logistics Market, for CDMOs/CMOs, 2018 - 2030 (USD Million)
  • Fig. 39 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 Regional Outlook, 2024 & 2030
  • Fig. 42 North America Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 48 UK Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 49 France Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 57 China Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 58 India Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 68 UAE Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait Cell & Gene Therapy Third-Party Logistics Market, 2018 - 2030 (USD Million)